NMRl Albino mice, in which the hepatic glutathione (CSH) content was decreased by nearly 50% by either the administration of a pure glucose diet or by starvation, were intoxicated with aryl halides, bromobenzene, and iodobenzene (13 and 9 mmol/kg body weight, respectively, p.0.). After both intoxications, the hepatic glutathione content decreased rapidly to very low values, and liver necrosis, as assessed by serum transaminase levels, occurred in about 45 or 60% of the animals (in the case of bromobenzene or iodobenzene, respectively) after a lag phase of 9 or 6 hr. In both instances liver necrosis was evident only when the hepatic CSH depletion reached a threshold value (3.5-2.5 nmols/ mg protein). The same threshold value was evident for the occurrence of lipid peroxidation (measured as both carbonyl functions and conjugated dienes in liver phospholipids).
INTRODUCTION
A variety of hepatotoxic chemicals produce liver cell damage by means of active metabolites resulting from the biotransformation of the parent molecules in the mixed-function monooxygenase system of the hepatic endoplasmic reticulum.
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A number of xenobiotics (among which are bromobenzene and its analogs, acetaminophen, etc.) can form conjugates with hepatic glutathione (GSH) thus producing consistent depletion of GSH in the liver cell. According to Anundi et al. (4) such a depletion in isolated hepatocytes treated with a number of GSH-depleting agents, results in the onset of lipid peroxidation.
We have studied the mechanisms of bromobenzene and iodobenzene hepatotoxicity in vivo, startingwith the possibility that GSH depletion could produce in liver cells a condition of increased oxidative stress resulting in the onset of lipid peroxidation; and that lipid peroxidation rather than covalent binding could be responsible for liver necrosis.
METHODS
NMRI Albino male mice were used in this study since they were more susceptible to bromobenzene and iodobenzene intoxication than rats. In most experiments the animals were fed a pure glucose diet for 2 days before the intoxication to decrease the hepatic GSH content to about 50% of the initial level, according to the protocol followed by others (5). This initial depletion of GSH was necessary in order to obtain significant development of liver necrosis after the intoxications.
Liver necrosis was assessed by measuring the level of serum transaminases (glutamate pyruvate [SGPT) and glutamate oxaloacetate (SG OT)) .
Lipid peroxidation of liver cell membranes was assessed with two different procedures: 1) by measuring dienc conjugation absorption in liver phospholipids (6) and 2) by measuring the amount of carbonyl functions originating from the peroxidative breakdown of unsaturated fatty acids in cellular phospholipids, as reported by Benedetti et al. (7) . As a result of the peroxidative cleavage of unsaturated fatty acids, in fact, acyl residues bearing car-bony1 functions are formed in membrane phospholipids (8). These carbonyl functions can be detected after derivatization with 2,4dinitrophenylhydrazine [DNPH) and separation of phospholipids from neutral lipids and unreacted DNPH (7) . The absorption spectrum of DNPH derivatives of peroxidized phospholipids is similar to that obtained with a mixture of dinitrophenylhydrazones of standard aldehydes (7) .
RESULTS AND DISCUSSION
In the first set of experiments, glucose-fed mice were treated with a dose of 13 mmol/ kg body weight of bromobenzene [when labeled bromobenzene was used, the same dose contained 70 pCi of br~mo[U-'~C]benzene/ mmol). Hepatic GSH content, liver necrosis (as measured by the level of serum transaminases), lipid peroxidation [as measured by both the presence of carbonyl functions and the appearance of dienc conjugation absorption in liver phospholipids), and the covalent binding of bromobenzene metabolites to liver proteins were determined at various times ,after the intoxication. The hepatic GSH level was decreased at 3,9, and 14 hr after poisoning by 69, 77, and 85%, respectively, as compared with the glucose-fed, nonintoxicated animals. Liver necrosis, while absent at 3 and 9 hr, was clearly evident at 14 hr in nearly 45% of the animals. Lipid peroxidation, which was minimal or absent at 3 and 9 hr after poisoning, was found to occur at 14 hr in the animals showing hepatic necrosis. At 14 hr, the greatest covalent binding of ["C] bromobenzene metabolites to liver proteins (2.05 -C 0.18 nmol/mg protein) was observed.
Since a large individual variation was observed in the sensitivity of the animals to bromobenzene (as stated above liver necrosis was present in nearly 45% of the animals 14 hr after bromobenzene dosing), it seemed useful to consider the values of the parameters studied for each individual animal. When the individual transaminase values at 14 hr were plotted against the respective hepatic GSH contents ( Fig. I ), liver necrosis was clearly evident only when the hepatic GSH depletion reached a threshold value (3.5-2.5 nmol/mg protein). Such a threshoId value of hepatic GSH was equally evident for the onset of lipid peroxidation in liver phospholipids ( Fig. I) , even though in some instances in which liver necrosis was minimal or absent, evidence of lipid peroxidation was detected.
Similar results were obtained with iodobenzene, a more toxic analog of bromoben- zene. In this case the experiments were run with mice starved overnight rather than fed glucose for 2 days; the GSH depletion with overnight starvation was similar to that obtained with glucose feeding, and the starved animals tolerated the iodobenzene poisoning better than glucose-fed animals. Iodobenzene was administered at the dose of 9 mmol/kg and the mice were killed 12-16 hr later. As in the case of bromobenzene, the plot of the individual values of serum transaminase levels against the hepatic GSH contents revealed that the same threshold value (3.5-2.5 nmol/mg protein) of hepatic GSH depletion as that seen in the case of bromobenzene intoxication must be reached before clearcut necrosis occurs.
The same threshold value is evident for the occurrence of lipid peroxidation. Therefore, as in bromobenzene intoxication, the two phenomena appear related.
In order to investigate whether the depletion of hepatic GSH content is capable by itself of inducing lipid peroxidation and necrosis to the liver, we studied the effects of the administration to mice of diethylmaleate, which can be expected, at least to a certain extent, to conjugate directly with GSH without previous metabolism. Therefore, glucosefed mice were given 1 2 mmol/kg body weight of diethylmaleate by gastric intubation and killed 15-20 hr later. Of 14 animals, 5 animals developed liver necrosis, which occurred only below the same threshold value of hepatic GSH as that seen in the case of bromobenzene and iodobenzene poisoning (3.5-2.0). Again lipid peroxidation occurred in diethylmaleate-dosed mice at the same threshold limits seen for liver necrosis. In only one case both liver necrosis and lipid peroxidation occurred when hepatic GSH content (5.0 nmol/mg protein) was above the threshold value.
The covalent binding of reactive metabolites to liver protein was measured using "C-labeled bromobenzene for the intoxication. When the extent of the covalent binding measured at 14 hr was plotted against the GSH level, as was done in the case of transaminases and lipid peroxidation, the values appeared much more dispersed and no obvious relationship between a critical concen-tration of hepatic GSH and the extent of the covalent binding could be observed.
The analysis of the results obtained in the bromobenzene study showed that while a correlation with a high statistical significance ( p < 0.0001) was found between lipid peroxidation and necrosis (log of carbonyl functions and log of SGPT), a correlation with a much lower significance ( p < 0.05) was found between covalent binding and necrosis (log of covalently bound bromobenzene and log of SGPT).
In order to further evaluate the relative roles played by lipid peroxidation and by covalent binding of bromobenzene metabolites to cellular proteins in the production of liver necrosis, experiments were carried out in which an effective antioxidant was administered to the animals after bromobenzene intoxication. The aim of the experiment was to prevent the development of extensive lipid peroxidation, to see whether or not liver necrosis was also prevented under such conditions, and to evaluate the extent of the covalent binding of ["C]bromobenzene metabolites to liver proteins in these animals. To this end ["C]bromobenzene was given to the animals as previously described. After dosing, the animals were divided into two groups: one received intraperitoneally Trolox C, a lower homolog of vitamin E (270 pmols/ kg. in propylene glycol), 9 and 1 3 hr after bromobenzene dosing; the other group received the vehicle only. The animals were killed 16 hr after poisoning. In the group not receiving Trolox C, four of nine mice developed severe liver necrosis and three developed a moderate lesion; whereas, in the group receiving the antioxidant Trolox C, no animal developed massive necrosis, four had only moderate lesions, and the other six were completely protected. The extent of lipid peroxidation was, in every case, comparable to the extent of liver necrosis; i.e., in the animals not receiving Trolox C, very extensive lipid peroxidation was matched by massive necrosis and so on; whereas in the animals given Trolox C, lipid peroxidation was minimal or absent. Therefore, Trolox C prevents both lipid peroxidation and liver necrosis and the two phenomena appear to be causally related. Furthermore, in the experiment with Trolox C the covalent binding of [l'C]bromobenzene metabolites to liver proteins appeared to be completely dissociated from liver necrosis. In fact, the values for covalent binding were rather uniform in the various subgroups (without statistical differences among them]; in particular, the values for covalent binding in the animals treated with Trolox C were not different from those seen in the animals not treated with Trolox C (Table I ). It seems therefore that, at least in this experimental model, lipid peroxidation and not covalent binding is the cause of liver cell death.
The conclusions which can be drawn from the present results are the following. First, the depletion in hepatic GSH content caused by bromobenzene and iodobenzene intoxications in vivo results in the occurrence of extensive lipid peroxidation and necrosis only when a well-defined threshold value of GSH is reached; second, lipid peroxidation rather than the covalent binding of the metabolites of the toxins to cellular proteins seems to be responsible for liver damage.
Furthermore, the experiments with diethylmaleate show that, 15-20 hr after the intoxication, lipid peroxidation and necrosis were present in the mice in which the hepatic GSH depletion reached the same threshold limits as seen with bromobenzene and iodobenzene. Since diethylmaleate can react directly with GSH without previous metabolism, this would imply that the depletion of hepatic GSH is capable by itself of producing lipid peroxidation and necrosis. Diethylmaleate may have, however, unknown effects that result in the induction of lipid peroxidation unrelated to the depletion of GSH. Further studies are needed to clarify this point.
